xmlns:atom="http://www.w3.org/2005/Atom" xmlns:atom="http://www.w3.org/2005/Atom"
297.—(1) A person may not as part of the promotion of a medicinal product send or deliver any written material to a person qualified to prescribe or supply medicinal products unless the material—
(a)[F1subject to paragraph (1A),] contains particulars in accordance with all the paragraphs of Schedule 30; and
(b)states the date on which it was drawn up or last revised.
[F2(1A) Paragraph 1 of Schedule 30 does not apply in the case of a product in relation to which there is in force an authorisation by the licensing authority on a temporary basis under regulation 174.]
(2) A person may not include any information in written material to which paragraph (1) applies unless it—
(a)is accurate;
(b)is up-to-date;
(c)can be verified; and
(d)is sufficiently complete to enable the recipient to form an opinion of the therapeutic value of the product to which it relates.
(3) A person may not include any illustrative material in written material to which paragraph (1) applies unless—
(a)the illustrative material is accurately reproduced; and
(b)the written material indicates the precise source of the illustrative material.
(4) In this regulation “illustrative material” means a quotation, table or any other illustrative material taken from a medical journal or other scientific work.
Textual Amendments
F1Words in reg. 297(1)(a) inserted (6.11.2020) by The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 (S.I. 2020/1125), regs. 1(2), 28(2) and words in reg. 297(1)(a) inserted (N.I.) (6.11.2020) by The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 (S.R. 2020/349), regs. 1(2), 28(2)
F2Reg. 297(1A) inserted (6.11.2020) by The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 (S.I. 2020/1125), regs. 1(2), 28(3) and reg. 297(1A) inserted (N.I.) (6.11.2020) by The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 (S.R. 2020/349), regs. 1(2), 28(3)